Detection of CTX-M-15 and CTX-M-33, a novel variant of CTX-M-15, in clinical Escherichia coli isolates in Greece
Authors:
- Irene GalaniIrene Galani
- Maria SouliMSMaria Souli
- Zoi ChryssouliZCZoi Chryssouli
- Helen GiamarellouHGHelen Giamarellou
- 31 May 2007
- journal article
- other
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 29 (5) , 598-600
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A novel ceftazidime-hydrolysing extended-spectrum -lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loopJournal of Antimicrobial Chemotherapy, 2006
- A novel extended-spectrum -lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistanceJournal of Antimicrobial Chemotherapy, 2004
- CTX-M enzymes are the most common extended-spectrum -lactamases among Escherichia coli in a tertiary Greek hospitalJournal of Antimicrobial Chemotherapy, 2004
- Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3Journal of Antimicrobial Chemotherapy, 2002
- CTX-M-3 β -Lactamase-Producing Escherichia coli from GreeceMicrobial Drug Resistance, 2002
- CTX-M-1, CTX-M-3, and CTX-M-14 β-Lactamases from Enterobacteriaceae Isolated in FranceAntimicrobial Agents and Chemotherapy, 2002
- PCR mapping of integrons reveals several novel combinations of resistance genesAntimicrobial Agents and Chemotherapy, 1995